Immunosurveillance and Regression in the Context of Squamous Pulmonary Premalignancy.


In this issue of <i>Cancer Discovery</i>, Pennycuick and colleagues comprehensively evaluate the immune contexture of progressive and regressive lesions in squamous pulmonary premalignancy. The authors dissect the molecular features of these lesions and the potential pathways of immune escape operative in progression to invasive cancer.<i>See related article by Pennycuick et al., p. 1489</i>.

  • Dubinett SM
  • Krysan K
  • Tran LM
PubMed ID
Appears In
Cancer Discov, 2020, 10 (10)